Literature DB >> 2514232

Monoclonal antibody two-site ELISA for human IFN-gamma. Adaptation for determinations in human serum or plasma.

G Andersson1, H P Ekre, G Alm, P Perlmann.   

Abstract

Mouse monoclonal antibodies (mAbs) against human interferon-gamma (IFN-gamma) were produced after immunization with recombinant IFN-gamma. Two mAbs (1-D1K and 7-B6-1) recognizing distinct epitopes on natural IFN-gamma were selected for the development of a two-site ELISA. The sensitivity was similar for IFN-gamma diluted in PBS with 1% bovine albumin, spent culture medium or fetal calf serum but reduced to approximately 50% when diluted in normal human serum. Individual normal human sera were tested and three of 14 gave false reactivities in the ELISA. One serum factor with major impact on the individual variation and the decreased sensitivity could be adsorbed to and eluted from protein A-Sepharose. Based on these observations we established a new ELISA protocol which made it possible to test for low levels of IFN-gamma in human serum and plasma samples. The modifications in this protocol are easy to apply with basic laboratory equipment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514232     DOI: 10.1016/0022-1759(89)90081-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  23 in total

1.  Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.

Authors:  M Troye-Blomberg; E M Riley; L Kabilan; M Holmberg; H Perlmann; U Andersson; C H Heusser; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.

Authors:  A K Ulfgren; S Lindblad; L Klareskog; J Andersson; U Andersson
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

3.  Persistence of local cytokine production in shigellosis in acute and convalescent stages.

Authors:  R Raqib; A A Lindberg; B Wretlind; P K Bardhan; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

4.  Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.

Authors:  L Kabilan; V P Sharma; P Kaur; S K Ghosh; R S Yadav; V S Chauhan
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood.

Authors:  J Andersson; U Andersson
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

6.  Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.

Authors:  R Karttunen; H M Surcel; G Andersson; H P Ekre; E Herva
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

7.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

8.  High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors.

Authors:  M Quiding; G Granström; I Nordström; B Ferrua; J Holmgren; C Czerkinsky
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  Myelin antigen reactive T cells in cerebrovascular diseases.

Authors:  W Z Wang; T Olsson; V Kostulas; B Höjeberg; H P Ekre; H Link
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

10.  Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.

Authors:  U G Andersson; L Björk; U Skansén-Saphir; J P Andersson
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.